27 - New Effectors of TB Immunity: Beyond CD4 T-Cells

10/3/2019

10:30 AM - 11:45 AM

Room: Walter E. Washington Convention Center, 152 AB

MOC Credit: Maximum of 1.25 hours of MOC Credit
CME Credit: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
ACPE Credit: ACPE 0 knowledge-based contact hours of pharmacy CE
ACPE Number: no ACPE

Learning Objectives:

At the conclusion of this session, participants will be able to:

identify the contributions, both proven and hypothesized, for antibodies in host defense against TB infection
distinguish between the contributions of neutrophils and adaptive T-cell immunity in TB defense
define the importance of Type I Interferon and IL1-Beta in determining TB susceptibility and disease severity

Presentations:

10:30 AM - 10:55 AM
64 - Cytokine and Lipid mediator Crosstalk in M. Tuberculosis Host Defense
Katrin Mayer-Barber, PhD – National Institute of Allergy and Infectious Diseases
10:55 AM - 11:20 AM
65 - New Insights into the Role of Humoral Immunity in TB Defense
Babak Javid, MB, BChir, PhD, MRCP – Tsinghua University School of Medicine
11:20 AM - 11:45 AM
66 - Beyond Pus: Neutrophils in Host Defense Against Tuberculosis
Christina Stallings, PhD – Washington University

Moderator(s)

Michael Glickman, MD, FIDSA, FAAM

Member, Attending Physician
Memorial Sloan Kettering
New York, New York

Disclosure: Takeda: Consultant, Independent Contractor
Vedanta Biosciences: Advisory Board, Consultant, Independent Contractor

Speaker(s)

BJ

Babak Javid, MB, BChir, PhD, MRCP

Principal Investigator (tenured)
Tsinghua University School of Medicine
Haidian Qu, Beijing Shi, China (People's Republic)

Disclosure: Boeringher-Ingelheim: Grant/Research Support, Research Grant
Katrin Mayer-Barber, PhD

Earl Stadtman Investigator
National Institute of Allergy and Infectious Diseases
Bethesda, MD

Disclosure: Nothing to disclose
Christina Stallings, PhD

Associate Professor
Washington University
St. Louis, MO

Disclosure: Nothing to disclose